Inflammatory markers for predicting responses to nivolumab in patients with metastatic renal cell carcinoma

Int J Urol. 2020 Apr;27(4):350-351. doi: 10.1111/iju.14190. Epub 2020 Feb 5.
No abstract available

MeSH terms

  • Antineoplastic Agents, Immunological*
  • Biomarkers
  • Carcinoma, Renal Cell* / drug therapy
  • Humans
  • Kidney Neoplasms* / drug therapy
  • Nivolumab*

Substances

  • Antineoplastic Agents, Immunological
  • Biomarkers
  • Nivolumab